ArticleCancer discovery2015

Ligand-independent EPHA2 signaling drives the adoption of a targeted therapy-mediated metastatic melanoma phenotype.

Kim H T Paraiso et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.